Question

A 65 year old man with long standing hypertension and hyperlipidaemia has a 10 year cardiovascular risk of 18 percent calculated using QRISK3. He has no established cardiovascular disease. According to updated NICE lipid modification guidance, what is the recommended primary prevention strategy regarding statins?

Accepted Answer

Offer Atorvastatin 20 mg daily as first line primary prevention

Answer

Do not offer statins as his risk is below 20 percent

Answer

Offer Atorvastatin 80 mg daily for primary prevention

Answer

Reserve statins only for secondary prevention

Answer

Offer statins only if his QRISK3 exceeds 30 percent

Practice question